VIEMED HEALTHCARE INC (VMD)
Health Care · Home medical equipment and post-acute healthcare services · NASDAQ
Viemed provides home-based respiratory, chronic care, and women's health services with clinical practitioners delivering therapy and equipment rental to patients across all 50 US states.
What VIEMED HEALTHCARE INC does
Viemed Healthcare is a provider of home medical equipment (HME) and post-acute healthcare services in the United States, focusing on respiratory disease management, chronic care, and women's health products delivered in patients' homes. The company rents and sells medical equipment such as ventilators, BiPAP/CPAP devices, oxygen concentrators, and percussion vests, supported by a network of licensed respiratory therapists and clinical practitioners. Viemed also provides sleep apnea management, neuromuscular care, oxygen therapy, and healthcare staffing and recruitment services to third-party healthcare institutions. The company's model emphasizes reducing total healthcare costs and improving patient quality of life through technology-enabled, home-based clinical care and chronic disease management, serving patients across all 50 states.
Themes: home-based healthcare delivery, chronic disease management, respiratory disease (COPD, sleep apnea), post-acute care, cost-efficient care models, women's health (lactation/breast pumps), healthcare staffing / workforce solutions
Fundamentals
- Price$8.85 as of 2026-08-21 close
- Market cap$337M as of 2026-08-21
- 1-year return+25.5% 2025-08-21 close $7.05 → 2026-08-21 close $8.85
- P/E24.70 as of 2026-08-24
- Net margin+4.8% as of 2026-08-24
- Gross margin+57.5% as of 2026-08-24
- ROE+10.3% as of 2026-08-24
- Debt / equity0.05 as of 2026-08-24
- Revenue growth (YoY)+25.2% as of 2026-08-24
- Revenue CAGR (3y)+24.9% SEC XBRL
- Beta1.05 as of 2026-08-24
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
How VMD compares in its sector
- price-to-earnings ratiomiddle range 203 covered Health Care peers, as of 2026-08-24
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How VIEMED HEALTHCARE INC looks technically
VIEMED HEALTHCARE INC (VMD) is trading 0.9% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed above its 200-day average about 157 trading days ago — a "golden cross", a bullish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with sellers in control. Momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 28, in oversold territory (below 30). It made a new 20-day low about 2 trading days ago. It is 29.8% below its highest point of the past year. Trading volume is running unusually high — about 2.6× its 30-day average, a sign of heightened interest.
Trend
8
| Distance from the 200-day | it is trading 0.9% below its 200-day average, the long-term trend line — a long-term downtrend | -0.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $10.94 | $10.94 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $8.93 | $8.93 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 24 calendar days ago — the swings before that are what the structure reading is measured on | 24 sessions |
| Wave structure | its recent swings can be read as a completed three-part upward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes above 12.35. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave upward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 157 trading days ago — a "golden cross", a bullish long-term signal | 157 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with sellers in control | 40.9 |
Momentum
3
| 14-day RSI | momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 28, in oversold territory (below 30) | 28.3 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($8.51 to $10.56) — its "stochastic" reading is 17 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 16.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 28 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $12.61 | $12.61 |
|---|---|---|
| From the 52-week high | it is 29.8% below its 52-week high (its highest price of the past year) | -29.8% |
| Above the 52-week low | it is 46.3% above its 52-week low (its lowest price of the past year) | +46.3% |
| Below the 52-week high | it is 29.8% below its highest point of the past year | 29.8% |
| Since a 20-day breakout | it made a new 20-day low about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day low about 2 trading days ago | 2 sessions |
| All-time high | its highest closing price on record is $12.61 (set on 2026-07-13) | $12.61 |
| Given back of the 52-week move | over the past year its closes ranged ($6.26 to $12.33), and it has given back a bit over half of its rise from last year’s low — 57% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $8.38 to $8.58. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 57.3% |
| From the all-time high | it is 29.8% below its all-time high | -29.8% |
| Nearest price level | it is trading 1.5% below a resistance level at $8.98 — a price it turned at three times since 2024-12-02, most recently on 2026-02-06. Since 2024-08-21 it has 11 such levels below the current price and 4 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.5% |
| All-time low | its lowest closing price on record is $1.68 (set on 2018-01-04) | $1.68 |
| Above the all-time low | it is 426.0% above its all-time low | +426.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 98% of the past ~6 months) | 98th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.3965 between its high and its low — about 4.5% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.3965 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $7.61 and $12.43 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $7.61 – $10.02 – $12.43 |
| Typical daily range (% of price) | its price moves about 4.5% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.5% |
| Stretch from the 200-day average | it is trading 0.2 daily ranges below its 200-day average price (0.9% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.2 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is running unusually high — about 2.6× its 30-day average, a sign of heightened interest | 2.65× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|---|---|
| Since a bearish engulfing | 9 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 9 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.5% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.5% |
|---|---|---|
| Open gap | it gapped 9.7% below the previous close 13 sessions ago and has not traded back through the level it left behind at 11.69 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -9.7% |
| Gap filled | a 4.3% gap down opened on 2026-06-22 has been "filled" 43 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 43 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 28.1 percentage points (the stock lost 25.8% while the market gained 2.3%) | -28.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 11.2 percentage points (the stock lost 8.1% while the market gained 3.1%) | -11.2% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 3.7 percentage points (the stock gained 7.4% while the market gained 11.1%) | -3.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 5.1 percentage points (the stock gained 25.5% while the market gained 20.5%) | +5.0% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, its RSI momentum gauge is oversold (a beaten-down reading), near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a strong downtrend, with sellers in control, trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 16% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 13.8% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -15.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 9% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $9.74 — a volume-weighted average of daily closes over 155 sessions, not a true tick-by-tick VWAP. | -9.2% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% below the average price paid since it last reported on 2026-08-03 (its 10-Q), so the typical buyer over that stretch is under water. That average is $9.41 — a volume-weighted average of daily closes over 15 sessions, not a true tick-by-tick VWAP. | -6.0% |
Price levels it has turned at before
VMD last closed at $8.85 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 4 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $8.98 | Resistance | 1.5% above the last close | turned there three times · 2024-12-02 to 2026-02-06 |
| $8.62 | Support | 2.6% below the last close | turned there twice · 2025-01-27 to 2026-03-20 |
| $8.39 | Support | 5.2% below the last close | turned there four times · 2024-11-05 to 2026-05-06 |
| $9.42 | Resistance | 6.4% above the last close | turned there twice · 2024-10-24 to 2026-06-03 |
| $8.14 | Support | 8.0% below the last close | turned there twice · 2025-02-19 to 2026-02-23 |
| $9.86 | Resistance | 11.4% above the last close | turned there three times · 2024-11-07 to 2026-04-17 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part upward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes above $12.35.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Oversold (14-day RSI below 30) · Pulled back from the 12-month high · Unusually heavy trading volume · Broke down to a new 20-day low · At the bottom of its 14-day range (stochastic below 20) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (3.00 mean, 1=Strong Buy…5=Strong Sell) — 1 analyst
- Mean price target$11.00 range $11.00 – $11.00
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["Dependence on reimbursement rates from Medicare, Medicaid, and private insurers; changes to healthcare policy or reimbursement could negatively impact revenue and margins","Reliance on recruiting and retaining licensed respiratory therapists and clinical practitioners; shortage or increased labor costs could constrain growth and service quality","Regulatory compliance risks including medical device regulations, healthcare provider licensing, and privacy requirements across 50 states with varying requirements"]
What changed in the latest 10-Q
AI-assisted comparison of VMD's 10-Q filed 2026-05-05 against the prior one filed 2025-11-05.
Management's Discussion & Analysis (MD&A)
- Removed:
- Removed from newer filing (2026-05-05): reference to 'the Company's expectations about its acquisition of Lehan's Medical Equipment, such as contingent payments and the anticipated synergies and other benefits related thereto' in the Forward-Looking Statements section
- Notes:
- Both filings appear to be truncated at the same point ('By their nature, forward-looking statements involve numerous assumptions, inherent risks and uncertainties, both general and specific, including those identified under "'), limiting full comparison of the complete sections
Risk Factors
- Added:
- Newer filing (2026-05-05) includes a three-month period ended March 31, 2026 with condensed consolidated financial statements, whereas older filing (2025-11-05) covered nine-month period ended September 30, 2025
- Newer filing adds share repurchase activity: 150,000 shares repurchased for $1,245 thousand in Q1 2026
- Newer filing shows Distribution to non-controlling interest of $174 thousand in Q1 2026
- Removed:
- Older filing included nine-month comparative income statement data; newer filing removed nine-month presentation and provides only three-month comparison (Q1 2026 vs Q1 2025)
- Older filing presented detailed changes in shareholders' equity across multiple quarters (Dec 31 2023 through Sept 30 2025); newer filing condensed presentation to show only Dec 31 2025 and March 31 2026 balances
- Older filing included Finance lease right-of-use assets ($0 thousand at Sept 30, 2025 and $50 thousand at Dec 31, 2024) and Finance lease liabilities; newer filing removed these line items entirely
- Reworded:
- Item 1A. Risk Factors page reference changed from 42 (older) to 37 (newer)
- Item 2 page reference changed from 43 (older) to 37 (newer)
- Item 3 page reference changed from 43 (older) to 38 (newer)
- Item 4 page reference changed from 43 (older) to 38 (newer)
- Item 5 page reference changed from 43 (older) to 38 (newer)
- Item 6 page reference changed from 44 (older) to 39 (newer)
- Notes:
- The comparison covers different reporting periods (Q1 2026 vs nine months 2025), limiting direct operational comparability
- Older filing text appears truncated at end of cash flows section; full content may not be available for complete comparison
- Financial metric changes between periods may reflect seasonal variations and different time horizons rather than operational changes
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 6 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 6 sells ($347167) — 2 selling insiders
- Last 180 days0 buys · 9 sells ($2M) — 3 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-25. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about VMD's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding VMD as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 5,829,710
- Reported value $53,691,628
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
VMD had 671,738 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
VMD had 1.76% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.49 days to cover at the same settlement.
- Reported short interest (shares) 671,738
- Short interest (% of shares outstanding) 1.76%
- Prior settlement (shares) 747,076
- Reported change -10.08%
- Days to cover (reported) 2.49
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Linde (LIN)
- Air Liquide (AIQUY)
- AdaptHealth (AHCO)
- Apria (acquired by Owens & Minor)
- LHC Group (acquired by Optum/UnitedHealth)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare VMD vs…
VIEMED HEALTHCARE INC is found in…
Frequently asked questions
What does VIEMED HEALTHCARE INC (VMD) do?
Viemed Healthcare is a provider of home medical equipment (HME) and post-acute healthcare services in the United States, focusing on respiratory disease management, chronic care, and women's health products delivered in patients' homes. The company rents and sells medical equipment such as ventilators, BiPAP/CPAP devices, oxygen concentrators, and percussion vests, supported by a network of licensed respiratory therapists and clinical practitioners.
What sector is VIEMED HEALTHCARE INC (VMD) in?
VIEMED HEALTHCARE INC (VMD) is classified in the Health Care sector. Its industry is Home medical equipment and post-acute healthcare services. It trades on NASDAQ.
Who are VIEMED HEALTHCARE INC's (VMD) competitors?
Notable peers of VIEMED HEALTHCARE INC (VMD) include Linde, Air Liquide, AdaptHealth, Apria (acquired by Owens & Minor) and LHC Group (acquired by Optum/UnitedHealth). This peer set is informational only — not financial advice.
Is VIEMED HEALTHCARE INC (VMD) overbought or oversold right now?
VIEMED HEALTHCARE INC (VMD) is currently in oversold territory (its 14-day RSI is 28, below 30) (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on VMD come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.